Changes in Treatment Patterns and Their Influence on the Outcome of Systemic Sclerosis-interstitial Lung Disease (SSc-ILD) Patients: An EUSTAR Analysis

被引：0

作者：

Campochiaro, Corrado ^{[1
]}

Truchetet, Marie-Elise ^{[2
]}

Vonk, Madelon ^{[3
]}

Cuomo, Giovanna ^{[4
]}

Ananieva, Lidia P. ^{[5
]}

Hachulla, Eric ^{[6
]}

Smith, Vanessa ^{[7
]}

Gheorghiu, Ana Maria ^{[8
]}

Becvar, Radim ^{[9
]}

Hunzelmann, Nicolas ^{[10
]}

Furst, Daniel ^{[11
,12
]}

Ortiz-Santamaria, Vera

Carreira, Patricia ^{[13
]}

Del Galdo, Francesco ^{[14
]}

Cerinic, Marco Matucci ^{[15
]}

Hoffmann-Vold, Anna Maria ^{[16
]}

机构：

[1] Univ Vita Salute San Raffaele, IRCCS San Raffaele Hosp, Unit Immunol Rheumatol Allergy & Rare Disease, Milan, Italy

[2] Bordeaux Univ Hosp, Bordeaux, France

[3] Radboud Univ Nijmegen, Nijmegen Med Ctr, Nijmegen, Netherlands

[4] Luigi Vanvitelli Univ Campania, Dept Precis Med, Naples, Italy

[5] VA Nasonova Res Inst Rheumatol Russian Federat, Moscow, Russia

[6] Univ Lille, Lille, France

[7] Ghent Univ Hosp, Ghent, Belgium

[8] Ion Cantacuzino Clin Hosp, Dept Internal Med & Rheumatol, Bucharest, Romania

[9] Charles Univ Prague, Inst Rheumatol, Dept Rheumatol, Fac Med 1, Prague, Czech Republic

[10] Univ Ksln, Ksln, Germany

[11] Univ Calif Los Angeles, Los Angeles, CA USA

[12] Univ Granollers, Granollers, Spain

[13] Hosp Univ 12 Octubre, Madrid, Spain

[14] Univ Leeds, Leeds Inst Rheumat & Muskuloskeletal Med, Leeds, England

[15] IRCCS San Raffaele Hosp, Unit Immunol Rheumatol Allergy & Rare Dis, Milan, Italy

[16] Oslo Univ Hosp, Dept Rheumatol, Oslo, Norway

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0662

引用

页码：1323 / 1325

页数：3

共 50 条

[21] DOES ANTI-ACID TREATMENT INFLUENCE DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS INTERSTITIAL LUNG DISEASE (SSC-ILD)? DATA FROM THE GERMAN SSC-NETWORK
Kreuter, M.
Bonella, F.
Riemekasten, G.
Mueller-Ladner, U.
Henes, J.
Siegert, E.
Guenther, C.
Koetter, I.
Blank, N.
Pfeiffer, C.
Schmalzing, M.
Zeidler, G.
Korsten, P.
Susok, L.
Juche, A.
Worm, M.
Jandova, I.
Ehrchen, J.
Sunderkoetter, C.
Keyszer, G.
Ramming, A.
Schmeiser, T.
Kreuter, A.
Kuhr, K.
Lorenz, H. M.
Moinzadeh, P.
Hunzelmann, N.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1585 - 1585
[22] Trajectories of Forced Vital Capacity (FVC) in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
Distler, Oliver
Vonk, Madelon
Azuma, Arata
Mayes, Maureen
Khanna, Dinesh
Highland, Kristin B.
Toenges, Gerrit
Alves, Margarida
Allanore, Yannick
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 5170 - 5172
[23] EFFECTS OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN SUBGROUPS BY DISEASE ACTIVITY INDEX
Herrick, A.
Pope, J.
Carreira, P.
Miede, C.
Alves, M.
Allanore, Y.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 963 - 963
[24] Effect of nintedanib on circulating biomarkers in subjects with systemic sclerosis-associated interstitial lung disease (SSc-ILD)*
Prasse, Autoren A.
Assassi, S.
Kuwana, M.
Denton, C.
Maher, T.
Diefenbach, C.
Ittrich, C.
Gahlemann, M.
Distler, O.
PNEUMOLOGIE, 2023, 77 : S53 - S54
[25] EFFECTS OF NINTEDANIB ON CIRCULATING BIOMARKERS IN SUBJECTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD)
Assassi, S.
Kuwana, M.
Denton, C. P.
Maher, T.
Diefenbach, C.
Ittrich, C.
Gahlemann, M.
Distler, O.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 719 - 720
[26] Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network
Kreuter, M.
Bonella, F.
Blank, N.
Siegert, E.
Henes, J.
Worm, M.
Sunderkoetter, C.
Schmalzing, M.
Kreuter, A.
Guenther, C.
Susok, L.
Zeidler, G.
Koetter, I.
Mueller-Ladner, U.
Krieg, T.
Juche, A.
Schmeiser, T.
Riemekasten, G.
Aberer, E.
Gaebelein-Wissing, N.
Distler, J. H. W.
Sardy, M.
Pfeiffer, C.
Kuhr, K.
Lorenz, H.
Moinzadeh, P.
Hunzelmann, N.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[27] "EFFECTIVE LUNG AGE" IN SUBJECTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN THE SENSCIS TRIAL
Maher, T.
Bourdin, A.
Volkmann, E.
Vettori, S.
Distler, J. H. W.
Alves, M.
Stock, C.
Distler, O.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 447 - 447
[28] Rituximab for the treatment of systemic sclerosis-interstitial lung disease
Hughes, Michael
Denton, Christopher P.
Khanna, Dinesh
RHEUMATOLOGY, 2021, 60 (02) : 489 - 491
[29] CONTINUED TREATMENT WITH NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD): THREEYEAR DATA FROM SENSCIS-ON
Allanore, Y.
Vonk, M.
Distler, O.
Azuma, A.
Mayes, M.
James, A.
Kohlbrenner, V.
Alves, M.
Khanna, D.
Highland, K.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 281 - 281
[30] RISK OF MALNUTRITION IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD): FURTHER ANALYSES OF THE SENSCIS TRIAL
Volkmann, E.
Mcmahan, Z.
Johnson, S.
Smith, V.
Jouneau, S.
Miede, C.
Alves, M.
Herrick, A.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 674 - 674

← 1 2 3 4 5 →